The Future of Obesity Drugs

Last year Pfizer became the first company to do more than $100 billion in revenue in a single year. The thinking is that Obesity Drugs could ultimately become much bigger than COVID drugs were during the pandemic, only on an ongoing basis. Novon Nordisk and Eli Lilly are two companies out in front on this. And we've talked before about just how effective these new drugs are for weight loss relative to other drugs that have been tried in the past.